Cognitive Remediation Therapy (CRT) in Adolescents With EOS
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01701609|
Recruitment Status : Completed
First Posted : October 5, 2012
Last Update Posted : August 13, 2018
|Condition or disease||Intervention/treatment||Phase|
|Schizophrenia||Behavioral: Cognitive Remediation Therapy||Not Applicable|
Early-onset schizophrenia (EOS) is associated with worse course and poor outcome than adulthood schizophrenia. Cognitive deficits are known to be a core feature in EOS, with large deficits on almost all cognitive domains. Importantly, cognitive deficits are known to be strong predictors of psychosocial and functional outcomes in schizophrenia and also in the early-onset form of the illness. Cognitive Remediation Therapy (CRT) is a behavioral training based intervention that aims to improve cognitive processes (attention, memory, executive function, social cognition or metacognition) with the goal of durability and generalization. It has been demonstrated that CRT improve cognitive deficits and functional outcome in adult patients but there are very few studies with adolescent samples.
A controlled randomized study will be carry out with two groups: patients receiving treatment as usual plus CRT, and patients receiving treatment as usual (TAU). The independent variable is the cognitive remediation treatment. The CRT will be applied according to the manual of Wykes and Reeder (2005). The program has a duration of 40 sessions, with two session for week. It is carried out individually and utilizes paper and pencil tasks. The main technique utilized is the scaffolding in a context of learning without errors.
The main dependent variable is the cognitive performance measured through neuropsychological tests. Other secondary dependent variables are functional outcome and clinical symptoms obtained from the psychometric evaluation.
All participants will be evaluated before and after the experimental intervention in several neurocognitive domains, clinical symptoms and functional outcome. The evaluations will be carried out by expert evaluators. Intention-to-treat analysis will be carry out using the statistical package SPSS v 18.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||50 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Efficacy of a Cognitive Remediation Treatment in Adolescents With Schizophrenia Spectrum Disorders|
|Actual Study Start Date :||January 2007|
|Actual Primary Completion Date :||December 2012|
|Actual Study Completion Date :||July 2013|
Experimental: Cognitive Remediation Therapy
CRT: Frontal/Executive Program. The program has a duration of 40 sessions, with two session for week. Is is carried out individually and utilizes paper and pencil tasks. The main technique utilized is the scaffolding in a context of learning without errors.
Behavioral: Cognitive Remediation Therapy
- Cognitive performance [ Time Frame: 20 weeks ]Change from baseline in neuropsychological test scores of memory, executive functions, working memory and processing speed at post-treatment evaluation
- Functional outcome [ Time Frame: 20 weeks ]Change in real-world functioning scales, self-esteem and caregiver burden at post-treatment evaluation
- Symptoms [ Time Frame: 20 weeks ]Change from baseline in measures of clinical symptoms at post-treatment evaluation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01701609
|Department of Child and Adolescent Pyshicatry and Psychology|
|Barcelona, Catalunya, Spain, 08036|
|Principal Investigator:||Olga Puig, PhD||Hospital Clinic of Barcelona|
|Study Director:||Rafael Penadés, PhD||Hospital Clínic de Barcelona|
|Study Director:||Josefina Castro-Fornieles, MD||Hospital Clínic de Barcelona|